CIK 0001021561
- Accelerated filer
NU SKIN ENTERPRISES, INC.
Sign in to watch- Ticker
- NUS
- Exchange
- NYSE
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 870565309
- Phone
- +1 801-345-1000
- Business address
- 75 WEST CENTER ST, ATTN: GREGORY BELLISTON, PROVO, UT, 84601
- Former names
- NU SKIN ENTERPRISES INC, NU SKIN ASIA PACIFIC INC, NU SKIN ASIA INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-02 | CHANG JOSEPH Y Chief Scientific Officer | Sale | −25,000 | $40.77 | $1.0M | 21,234 |
| 2023-03-02 | CHANG JOSEPH Y Chief Scientific Officer | Exercise or conversion · Employee Stock Option (Right to Buy) | −600 | 0 | ||
| 2023-03-02 | CHANG JOSEPH Y Chief Scientific Officer | Exercise or conversion · Employee Stock Option (Right to Buy) | −24,400 | 59,410 | ||
| 2023-03-01 | LUND STEVEN Exec. Chairman of the Board | Gift | −9,050 | 113,574 | ||
| 2023-03-01 | CHANG JOSEPH Y Chief Scientific Officer | Exercise or conversion | +68,485 | $30.63 | $2.1M | 89,719 |
| 2023-03-01 | CHANG JOSEPH Y Chief Scientific Officer | Sale | −68,485 | $40.44 | $2.8M | 21,234 |
| 2023-03-01 | CHANG JOSEPH Y Chief Scientific Officer | Exercise or conversion · Employee Stock Option (Right to Buy) | −42,485 | 0 | ||
| 2023-03-01 | CHANG JOSEPH Y Chief Scientific Officer | Exercise or conversion · Employee Stock Option (Right to Buy) | −26,000 | 600 | ||
| 2023-02-28 | NAPIERSKI RYAN S President and CEO | Exercise or conversion | +10,000 | $30.63 | $306K | 178,784 |
| 2023-02-28 | NAPIERSKI RYAN S President and CEO | Sale | −9,400 | $40.38 | $380K | 169,384 |
| 2023-02-28 | NAPIERSKI RYAN S President and CEO | Sale | −600 | $40.97 | $25K | 168,784 |
| 2023-02-28 | NAPIERSKI RYAN S President and CEO | Exercise or conversion · Employee Stock Option (Right to Buy) | −10,000 | 0 | ||
| 2023-02-27 | NAPIERSKI RYAN S President and CEO | Exercise or conversion | +21,513 | $30.63 | $659K | 190,297 |
| 2023-02-27 | NAPIERSKI RYAN S President and CEO | Sale | −21,513 | $41.38 | $890K | 168,784 |
| 2023-02-27 | NAPIERSKI RYAN S President and CEO | Exercise or conversion · Employee Stock Option (Right to Buy) | −2,513 | 10,000 | ||
| 2023-02-27 | NAPIERSKI RYAN S President and CEO | Exercise or conversion · Employee Stock Option (Right to Buy) | −19,000 | 0 | ||
| 2023-02-23 | Thomas James D Chief Accounting Officer | Sale | −2,829 | $41.12 | $116K | 17,928 |
| 2023-02-22 | Battle Emma S. Director | Sale | −987 | $41.70 | $41K | 4,659 |
| 2023-02-22 | LIPMAN ANDREW D Director | Sale | −1,000 | $41.42 | $41K | 64,393 |
| 2023-02-22 | Thomas James D Chief Accounting Officer | Grant or award | +9,330 | 20,757 |
Page 9 of 15 · 288 trades